Mechanism of Action of Solriamfetol
Introduction Solriamfetol is an oral wakefulness-promoting drug marketed under the brand name Sunosi. Pharmacologically, solriamfetol is a dopamine and norepinephrine reuptake inhibitor, commonly abbreviated as DNRI. Excessive daytime sleepiness is a major symptom in narcolepsy and obstructive sleep apnea. In narcolepsy, sleep-wake regulation is disturbed, often due to abnormalities in wake-promoting and REM sleep-regulating pathways. … Read more